6-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20546

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

January 31, 2021

Commission File Number: 001-39251

BETTERWARE DE MÉXICO, S.A.P.I. DE C.V.

(Name of Registrant)

Luis Enrique Williams 549

Colonia Belenes Norte

Zapopan, Jalisco, 45145, México

+52 (33) 3836-0500

(Address of Principal Executive Office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒ Form 40-F ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐

RELEVANT INFORMATION

Betterware de Mexico S.A.P.I. de C.V. (Nasdaq: BWMX) (“Betterware”) announces the First Call to a General Ordinary Shareholders’ Meeting, to be held on February 11, 2022.

The purpose of this Report on Form 6-K is to furnish a free English translation of the Shareholders’ Meeting Agenda and of the form of Power of Attorney.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

BETTERWARE DE MÉXICO, S.A.P.I. DE C.V.
By:	/s/ Luis Campos
Name: Title:	Luis Campos Board Chairman

Date: January 31, 2022

Exhibit Index

Exhibit No.	Description
99.1	Agenda for the General Ordinary Shareholders Meeting.
99.2	Form of Power of Attorney

EX-99.1

Exhibit 99.1

English translation for reference purposes only.

BETTERWARE DE MÉXICO, S.A.P.I. DE C.V.

FIRST CALL

GENERAL ORDINARY SHAREHOLDERS' MEETING

I, the undersigned, in my capacity as Secretary of Betterware de México, S.A.P.I. de C.V. (the "Company"), pursuant to Clause Thirtieth of the Company's bylaws, and in accordance with the provisions of Articles 183 (one hundred eighty-three), 186 (one hundred eighty-six), 187 (one hundred eighty-seven) and other provisions of the General Corporations Law, hereby summons the shareholders of the Company, on first call, to an Ordinary General Shareholders' Meeting of the Company, to be held on February 11, 2022 beginning at 12:00 hours, at the Company's registered office, specifically at Av. Paseo Royal Country 4596, Torre Cube 2, 16th floor, Fraccionamiento Puerta de Hierro, Zapopan, Jalisco, 45116, Mexico (the "Meeting"), to address the matters contained in the following:

AGENDA

1. Presentation, discussion, amendment, and in its case, approval of the annual management report referred to article 28, section IV, subsection e) of the Securities Market Law and article 172 subsection b) of the General Law of Commercial Companies, for the fiscal year from January 1, 2021 to December 31, 2021.

2. Presentation, discussion, amendment, and in its case, approval of the annual report by the Audit and Corporate Practices Committee, for the fiscal year from January 1, 2021 to December 31, 2021.

3. Report on compliance with the tax obligations of the Company during the fiscal year from January 1, 2021 to December 31, 2021.

4. Presentation, discussion, amendment, and in its case, approval of the Company's audited and consolidated financial statements for the fiscal year from January 1, 2021 to December 31, 2021, including the report of the Company's external auditor.

5. Discussion, and in its case, approval of dividends payment.

6. Appointment, and in its case, ratification of the appointments of the members of the Board of Directors.

7. Appointment, and in its case, ratification of the appointments of the Chairman and members of the Company's Audit and Corporate Practices Committee.

8. Discussion, and in its case, determination of the emoluments corresponding to the members of the Board of Directors and members of the Company's Audit and Corporate Practices Committee.

9. Discussion, and in its case, approval of the execution of a certain stock purchase agreement of the capital stock of Jafra Cosmetics International, Inc. and Jafra Mexico Holding Company B.V.

10. Discussion, and in its case, approval of the execution of certain financing by the Company, as borrower, and Banco Nacional de México, S.A., Grupo Financiero Banamex, and HSBC México, S.A., Institución de Banca Múltiple, Grupo Financiero HSBC, as structuring agents and as lenders.

11. Discussion, and in its case, ratification of the transaction documents.

12. Discussion, and in its case, ratification of the granting of powers of attorney to represent the Company in all necessary and/or convenient acts related to the previous items on the Agenda.

13. Appointment of special delegates to formalize the resolutions adopted at the Meeting.

English translation for reference purposes only.

The shareholders of the Company, in order to be entitled to attend the Meeting, must obtain an admission pass, which will be issued and delivered by the Secretary of the Board of Directors of the Company at the address indicated herein, up to and including the fourth business day prior to the Meeting, in the following terms:

a. Shareholders must be registered, either in the Company's Share Registry Book, or prove ownership of shares or certificates in accordance with the provisions of Articles 290 and 293 of the Securities Market Law and the Company's bylaws, i.e., through the certificates of deposit issued by the depository institutions where the shares they own are deposited. The shareholders' registry will remain closed from the third business day prior to the Meeting and on the day of the Meeting.

b. The shareholders must deposit their stock certificates, mentioned in (a) above, at the offices of the Company indicated herein, or at any national or foreign depository institution, and must present to the Company the corresponding certificate of deposit, which must be issued for such purposes, by the institution that holds such securities in favor of the shareholders.

c. Shareholders may attend the Meeting in person or may be represented by the authorized person or persons by means of a proxy form in terms of Article 49, Section III of the Securities Market Law, or by any other form of representation granted in accordance with the Law; therefore, shareholders must, if applicable, in addition to the proof of deposit mentioned in item (b) above, attach the proxy form referred to in this paragraph, which may be requested at the address indicated below or by e-mail to the following address: Reynaldo.Vizcarra-Mendez@bakermckenzie.com.

d. Likewise, shareholders who maintain custody of their shares through brokerage firms and other financial intermediaries are reminded that, for purposes of obtaining the admission pass, they must submit the list of holders issued for such purpose by such financial intermediary, which must contain the name, address, nationality of the shareholders and number of shares they represent, duly signed by the officer responsible for issuing such list.

The shares that the shareholders or their representatives deposit with the Secretary of the Board of Directors of the Company, in order to have the right to attend the Meeting, shall not be returned until after the Meeting has been held.

Notice is hereby given that the proxy forms, admission passes and supporting documentation that will serve as the basis for the discussion of the matters listed in the Agenda, will be available to the shareholders at the offices located in this Secretary's Office, as of this date from 9:00 a.m. to 2:00 p.m. and from 4:00 p.m. to 6:00 p.m. on business days; as well as electronically upon written request sent to the following e-mail address: Reynaldo.Vizcarra-Mendez@bakermckenzie.com.

It is communicated that adequate measures will be taken to take care of the prevention protocols due to the health contingency and that the venue where the Meeting will be held will be sufficiently large for attendees to keep a healthy distance.

We will communicate in a timely manner in the event that any legal provision is issued that leads us to modify the content of this call for proposals.

January 27, 2022.

______________________________

Reynaldo Vizcarra Méndez

Secretary of the Company

EX-99.2

Exhibit 99.2

Poder / Form of Power of Attorney

Carta Poder / Proxy Letter

___________________ (la “Poderdante”), por medio de la presente carta otorgo un poder especial pero tan amplio como sea requerido, en favor de ____________________ (el “Apoderado”) para que, asista a la Asamblea General Ordinaria de Accionistas de Betterware de Mexico, S.A.P.I. de C.V. (la “Sociedad”), que se celebrará el 11 de febrero de 2022 (la “Asamblea”), en la cual los accionistas de la Sociedad resolverán los siguientes puntos del Orden del Día; y voten en el sentido que se señala a continuación, en dicha Asamblea, _______________________ acciones que de dicha Sociedad la Poderdante es titular:

Orden del Día de la Asamblea Ordinaria de Accionistas

		A favor	En contra	Abstención
I.	Presentación, discusión, modificación, y en su caso, aprobación del informe anual del Consejo de Administración, a que se refiere el inciso e) de la fracción IV del artículo 28 de la Ley del Mercado de Valores y el artículo 172 inciso b) de la Ley General de Sociedades Mercantiles, por el ejercicio social comprendido del 1 de enero de 2021 al 31 de diciembre de 2021.
II.	Presentación, discusión, modificación, y en su caso, aprobación del informe anual por parte del Comité de Auditoría y Prácticas Societarias por el ejercicio social comprendido del 1 de enero de 2021 al 31 de diciembre de 2021.
III.	Informe sobre el cumplimiento de las obligaciones fiscales a cargo de la Sociedad durante el ejercicio social comprendido del 1 de enero de 2021 al 31 de diciembre de 2021.
IV.	Presentación, discusión, modificación, y en su caso, aprobación de los estados financieros consolidados de la Sociedad con motivo del ejercicio social comprendido del 1 de enero de 2021 al 31 de diciembre de 2021.

___________________ (the “Principal”), hereby grants a special power of attorney as broad as it may be required, in favor of ______________________ (the “Attorney-in-Fact”) so that, attends the General Ordinary Shareholders Meeting of Betterware de Mexico S.A.P.I. de C.V. (the “Company”), to be held on February 11, 2022 (the “Meeting”), through which the shareholders of the Company will resolve the matters contained in the following Agenda; and vote in the manner set fort below, in such Meeting, _____________________________ shares owned by the Principal:

Agenda for the General Ordinary Shareholders Meeting

		In favor	Against	Abstention
I.	Presentation, discussion, amendment, and in its case, approval of the annual management report referred to article 28, section IV, subsection e) of the Securities Market Law and article 172 subsection b) of the General Law of Commercial Companies, for the fiscal year from January 1, 2021 to December 31, 2021.
II.	Presentation, discussion, amendment, and in its case, approval of the annual report by the Audit and Corporate Practices Committee, for the fiscal year from January 1, 2021 to December 31, 2021.
III.	Report on compliance with the tax obligations of the Company during the fiscal year from January 1, 2021 to December 31, 2021.
IV.	Presentation, discussion, amendment, and in its case, approval of the Company's audited and consolidated financial statements for the fiscal year from January 1, 2021 to December 31, 2021, including the report of the Company's external auditor.
V.	Discussion, and in its case, approval of dividends payment.

V.	Discusión, y en su caso, aprobación del pago de dividendos.
VI.	Designación, y en su caso, ratificación de los nombramientos de los miembros del Consejo de Aministración.
VII.	Designación, y en su caso, ratificación de los nombramientos del Presidente y los miembros del Comité de Auditoría y Prácticas Societarias de la Sociedad.
VIII.	Discusión, y en su caso, determinación de los emolumentos correspondientes a los miembros del Consejo de Administración y miembros del Comité de Auditoría y Prácticas Societarias de la Sociedad.
IX.	Discusión y en su caso, aprobación de la celebración de cierto contrato de compraventa de acciones representativas del capital social de Jafra Cosmetics International, Inc. y Jafra Mexico Holding Company B.V.

VI.	Appointment, and in its case, ratification of the appointments of the members of the Board of Directors.
VII.	Appointment, and in its case, ratification of the appointments of the Chairman and members of the Company's Audit and Corporate Practices Committee.
VIII.	Discussion, and in its case, determination of the emoluments corresponding to the members of the Board of Directors and members of the Company's Audit and Corporate Practices Committee.
IX.	Discussion, and in its case, approval of the execution of a certain stock purchase agreement of the capital stock of Jafra Cosmetics International, Inc. and Jafra Mexico Holding Company B.V.

X.	Discusión y, en su caso, aprobación de la celebración de cierto financiamiento por parte de la Sociedad, como acreditada, y Banco Nacional de México, S.A., Grupo Financiero Banamex, y HSBC México, S.A., Institución de Banca Múltiple, Grupo Financiero HSBC, como agentes estructuradores y acreditantes.
XI.	Discusión y, en su caso, ratificación de los documentos de la operación.
XII.	Discusión y, en su caso, ratificación del otorgamiento de poderes para representar a la Sociedad en todos los actos necesarios y/o convenientes relacionados con los puntos anteriores del Orden del Día.
XIII.	Designación de delegados especiales para dar efecto y formalizar las resoluciones adoptadas en la Asamblea.

El Poderdante ratifica desde ahora los actos que realice el Apoderado en el ejercicio legal de este mandato.

X.	Discussion, and in its case, approval of the execution of certain financing by the Company, as borrower, and Banco Nacional de México, S.A., Grupo Financiero Banamex, and HSBC México, S.A., Institución de Banca Múltiple, Grupo Financiero HSBC, as structuring agents and as lenders.
XI.	Discussion, and in its case, ratification of the transaction documents.
XII.	Discussion, and in its case, ratification of the granting of powers of attorney to represent the Company in all necessary and/or convenient acts related to the previous items on the Agenda.
XIII.	Appointment of special delegates to formalize the resolutions adopted at the Meeting.

The Principal hereby ratifies the acts the Attorney-in-fact may conduct in the legal exercise of this mandate.

_____________ de 2022 / _________________, 2022

______________________________

Por/By:_______________________

Cargo/Title: ___________________________

Testigos/Witnesses

Name: Name: